Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.23
-0.01 (-0.81%)
At close: Sep 08, 2025, 3:59 PM
1.18
-4.07%
Pre-market: Sep 09, 2025, 05:43 AM EDT
-0.81% (1D)
| Bid | 1.23 |
| Market Cap | 39.71M |
| Revenue (ttm) | 18.79M |
| Net Income (ttm) | -16.14M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -2.28 |
| Forward PE | -4.43 |
| Analyst | n/a |
| Ask | 1.24 |
| Volume | 409,855 |
| Avg. Volume (20D) | 4,527,624 |
| Open | 1.24 |
| Previous Close | 1.24 |
| Day's Range | 1.21 - 1.25 |
| 52-Week Range | 1.12 - 8.40 |
| Beta | -0.73 |
About TELO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TELO
Website n/a
1 week ago
+0%
TELO stock has given up its prior gain. Telomir Ph...
Unlock content with
Pro Subscription
1 week ago
+0%
Telomir Pharmaceuticals shares are trading higher after highlighting in vitro results for Telomir-1.
